GlycoMimetics Ownership 2024 | Who Owns GlycoMimetics Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

57.22%

Insider Ownership

3.08%

Retail Ownership

39.70%

Institutional Holders

81.00

GlycoMimetics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL14.82%0.79%9,544,262--28,632,786Mar 31, 2024
ARTAL GROUP S.A.13.34%0.66%8,589,064--25,767,192Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC5.96%0.71%3,835,039-929,401-19.51%11,505,117Mar 31, 2024
OCTAGON CAPITAL ADVISORS LP4.66%1.08%3,000,000--9,000,000Mar 31, 2024
VANGUARD GROUP INC4.29%0.00%2,761,981340,11214.04%8,285,943Mar 31, 2024
AXA S.A.2.47%0.01%1,587,7414430.03%4,763,223Mar 31, 2024
GOLDMAN SACHS GROUP INC1.73%0.00%1,114,708195,35321.25%3,344,124Mar 31, 2024
MILLENNIUM MANAGEMENT LLC1.16%0.00%746,954708,0661820.78%2,240,862Mar 31, 2024
BLACKROCK INC.1.14%0.00%732,567-2,416-0.33%2,197,701Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.86%0.00%554,594554,594100.00%1,663,782Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC0.78%0.00%505,14726,2645.48%1,515,818Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.56%0.00%362,600362,600100.00%1,087,800Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.51%0.00%330,526-210,650-38.92%991,000Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.51%0.00%329,900329,900100.00%989,700Mar 31, 2024
JANE STREET GROUP, LLC0.45%0.00%289,275232,132406.23%867,825Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.34%0.00%220,348215,4954440.45%661,044Mar 31, 2024
MARSHALL WACE, LLP0.34%0.00%217,501204,6161588.02%652,503Mar 31, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.28%0.00%180,78737,42826.11%542,361Mar 31, 2024
STATE STREET CORP0.28%-179,265-7,500-4.02%537,795Mar 31, 2024
IKARIAN CAPITAL, LLC0.27%0.06%172,800172,800100.00%518,400Mar 31, 2024

GlycoMimetics's largest institutional shareholder is BVF INC/IL, holding 14.82% of the company's total share outstanding, currently valued at $28.63M. The top 10 institutional shareholders own together 50.42% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OCTAGON CAPITAL ADVISORS LP4.66%1.08%3,000,000--9,000,000Mar 31, 2024
BVF INC/IL14.82%0.79%9,544,262--28,632,786Mar 31, 2024
NEA MANAGEMENT COMPANY, LLC5.96%0.71%3,835,039-929,401-19.51%11,505,117Mar 31, 2024
ARTAL GROUP S.A.13.34%0.66%8,589,064--25,767,192Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.22%0.09%139,100139,100100.00%417,300Mar 31, 2024
SARGENT INVESTMENT GROUP, LLC0.17%0.07%108,00050,00086.21%324,000Mar 31, 2024
IKARIAN CAPITAL, LLC0.27%0.06%172,800172,800100.00%518,400Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.22%0.05%142,300142,300100.00%426,900Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.08%0.04%51,86851,868100.00%155,604Mar 31, 2024
INTELLECTUS PARTNERS, LLC0.08%0.04%50,720--152,160Mar 31, 2024
CTC ALTERNATIVE STRATEGIES, LTD.0.03%0.03%17,70017,700100.00%53,100Mar 31, 2024
AXA S.A.2.47%0.01%1,587,7414430.03%4,763,223Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.26%0.01%168,600-28,600-14.50%505,800Mar 31, 2024
TOBIAS FINANCIAL ADVISORS, INC.0.02%0.01%15,000--45,000Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD0.07%0.01%43,13016,55862.31%129,390Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.03%0.00%18,321-182,672-90.88%55,000Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.51%0.00%330,526-210,650-38.92%991,000Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.25%0.00%162,428162,428100.00%487,284Mar 31, 2024
HRT FINANCIAL LP0.24%0.00%155,830155,830100.00%467,000Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.07%0.00%45,60045,600100.00%136,800Mar 31, 2024

The largest GlycoMimetics shareholder by % of total assets is OCTAGON CAPITAL ADVISORS LP. The company owns 3.00M shares of GlycoMimetics (GLYC), representing 1.08% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MILLENNIUM MANAGEMENT LLC1.16%0.00%746,954708,0661820.78%2,240,862Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.86%0.00%554,594554,594100.00%1,663,782Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.56%0.00%362,600362,600100.00%1,087,800Mar 31, 2024
VANGUARD GROUP INC4.29%0.00%2,761,981340,11214.04%8,285,943Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.51%0.00%329,900329,900100.00%989,700Mar 31, 2024
JANE STREET GROUP, LLC0.45%0.00%289,275232,132406.23%867,825Mar 31, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.34%0.00%220,348215,4954440.45%661,044Mar 31, 2024
MARSHALL WACE, LLP0.34%0.00%217,501204,6161588.02%652,503Mar 31, 2024
GOLDMAN SACHS GROUP INC1.73%0.00%1,114,708195,35321.25%3,344,124Mar 31, 2024
IKARIAN CAPITAL, LLC0.27%0.06%172,800172,800100.00%518,400Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.25%0.00%162,428162,428100.00%487,284Mar 31, 2024
HRT FINANCIAL LP0.24%0.00%155,830155,830100.00%467,000Mar 31, 2024
MAN GROUP PLC0.23%0.00%149,859149,859100.00%449,577Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.22%0.05%142,300142,300100.00%426,900Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.22%0.09%139,100139,100100.00%417,300Mar 31, 2024
CITIGROUP INC0.21%0.00%137,667116,139539.48%413,001Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%116,100116,100100.00%348,300Mar 31, 2024
JPMORGAN CHASE & CO0.13%-84,62483,0115146.37%253,872Mar 31, 2024
MORGAN STANLEY0.16%-103,08868,577198.71%309,264Mar 31, 2024
AMERICAN CENTURY COMPANIES INC0.10%0.00%63,64263,642100.00%190,926Mar 31, 2024

As of Mar 31 2024, GlycoMimetics's largest institutional buyer is MILLENNIUM MANAGEMENT LLC. The company purchased 708.07K stocks of GLYC, valued at $2.24M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NEA MANAGEMENT COMPANY, LLC5.96%0.71%3,835,039-929,401-19.51%11,505,117Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.51%0.00%330,526-210,650-38.92%991,000Mar 31, 2024
GSA CAPITAL PARTNERS LLP0.03%0.00%18,321-182,672-90.88%55,000Mar 31, 2024
TWO SIGMA ADVISERS, LP0.05%0.00%29,300-136,100-82.29%87,900Mar 31, 2024
MJP ASSOCIATES INC /ADV----101,000-100.00%-Mar 31, 2024
ADVISOR OS, LLC----101,000-100.00%-Mar 31, 2024
FRANKLIN RESOURCES INC----95,751-100.00%-Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.06%0.00%35,698-60,061-62.72%107,000Mar 31, 2024
TWO SIGMA INVESTMENTS, LP----59,621-100.00%-Mar 31, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.26%0.01%168,600-28,600-14.50%505,800Mar 31, 2024
BANK OF NEW YORK MELLON CORP----24,732-100.00%-Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----19,384-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----12,464-100.00%-Mar 31, 2024
XTX TOPCO LTD----11,093-100.00%-Mar 31, 2024
STATE STREET CORP0.28%-179,265-7,500-4.02%537,795Mar 31, 2024
GROUP ONE TRADING, L.P.0.04%0.00%28,679-2,574-8.24%86,037Mar 31, 2024
BLACKROCK INC.1.14%0.00%732,567-2,416-0.33%2,197,701Mar 31, 2024
ORG PARTNERS LLC----500-100.00%-Mar 31, 2024
OCTAGON CAPITAL ADVISORS LP4.66%1.08%3,000,000--9,000,000Mar 31, 2024
BVF INC/IL14.82%0.79%9,544,262--28,632,786Mar 31, 2024

As of Mar 31 2024, GlycoMimetics's biggest institutional seller is NEA MANAGEMENT COMPANY, LLC. The company sold -0.93M shares of GLYC, valued at $11.51M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.86%0.00%554,594554,594100.00%1,663,782Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.56%0.00%362,600362,600100.00%1,087,800Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.51%0.00%329,900329,900100.00%989,700Mar 31, 2024
IKARIAN CAPITAL, LLC0.27%0.06%172,800172,800100.00%518,400Mar 31, 2024
VERITION FUND MANAGEMENT LLC0.25%0.00%162,428162,428100.00%487,284Mar 31, 2024
HRT FINANCIAL LP0.24%0.00%155,830155,830100.00%467,000Mar 31, 2024
MAN GROUP PLC0.23%0.00%149,859149,859100.00%449,577Mar 31, 2024
AFFINITY ASSET ADVISORS, LLC0.22%0.05%142,300142,300100.00%426,900Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.22%0.09%139,100139,100100.00%417,300Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.18%0.00%116,100116,100100.00%348,300Mar 31, 2024
AMERICAN CENTURY COMPANIES INC0.10%0.00%63,64263,642100.00%190,926Mar 31, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.08%0.04%51,86851,868100.00%155,604Mar 31, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.08%0.00%49,79849,798100.00%149,394Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC0.07%0.00%45,60045,600100.00%136,800Mar 31, 2024
BALYASNY ASSET MANAGEMENT L.P.0.06%0.00%40,55740,557100.00%121,671Mar 31, 2024
JEFFERIES FINANCIAL GROUP INC.0.06%0.00%38,20038,200100.00%114,600Mar 31, 2024
OMERS ADMINISTRATION CORP0.05%0.00%30,60030,600100.00%91,800Mar 31, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP0.04%0.00%23,33923,339100.00%70,017Mar 31, 2024
BELVEDERE TRADING LLC0.03%0.00%20,46520,465100.00%61,395Mar 31, 2024
SQUAREPOINT OPS LLC0.03%0.00%20,31520,315100.00%60,945Mar 31, 2024
JUMP FINANCIAL, LLC0.03%0.00%20,10320,103100.00%60,309Mar 31, 2024
SG AMERICAS SECURITIES, LLC0.03%0.00%18,80518,805100.00%56,000Mar 31, 2024
CTC ALTERNATIVE STRATEGIES, LTD.0.03%0.03%17,70017,700100.00%53,100Mar 31, 2024
LMR PARTNERS LLP0.02%0.00%14,10214,102100.00%42,306Mar 31, 2024
BELVEDERE TRADING LLC0.01%-3,6003,600100.00%10,800Mar 31, 2024
ROYAL BANK OF CANADA0.00%-2,0002,000100.00%6,000Mar 31, 2024
MACQUARIE GROUP LTD0.00%-1,9391,939100.00%6Mar 31, 2024
BELVEDERE TRADING LLC0.00%-1,4001,400100.00%4,200Mar 31, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A0.00%0.00%500500100.00%1,500Mar 31, 2024
FMR LLC0.00%-6767100.00%201Mar 31, 2024

GlycoMimetics's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 554.59K shares, valued at $1.66M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MJP ASSOCIATES INC /ADV----101,000-100.00%-Mar 31, 2024
ADVISOR OS, LLC----101,000-100.00%-Mar 31, 2024
FRANKLIN RESOURCES INC----95,751-100.00%-Mar 31, 2024
TWO SIGMA INVESTMENTS, LP----59,621-100.00%-Mar 31, 2024
BANK OF NEW YORK MELLON CORP----24,732-100.00%-Mar 31, 2024
683 CAPITAL MANAGEMENT, LLC----19,384-100.00%-Mar 31, 2024
BOOTHBAY FUND MANAGEMENT, LLC----12,464-100.00%-Mar 31, 2024
XTX TOPCO LTD----11,093-100.00%-Mar 31, 2024
ORG PARTNERS LLC----500-100.00%-Mar 31, 2024

GlycoMimetics's largest sold out institutional shareholder by shares sold is MJP ASSOCIATES INC /ADV, sold -0.10M shares, valued at -, as of undefined.

GlycoMimetics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS0.11%54,900--Dec 31, 2023
Federated Hermes MDT Series0.09%212,114--Jan 31, 2024
BRIDGEWAY FUNDS INC0.08%191,80025,00014.99%Dec 29, 2023
ALGER FUNDS0.06%55,000--Jan 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.05%8,547--Dec 29, 2023
ETFis Series Trust I0.04%62,689--Jan 31, 2024
Vericimetry Funds0.03%3,180--Dec 31, 2023
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.03%975,207--Jan 31, 2024
FORUM FUNDS II0.03%24,900--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.02%78,191--Feb 29, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%5,874--Dec 31, 2023
AMG FUNDS III0.01%1,426--Feb 29, 2024
QUANTITATIVE MASTER SERIES LLC0.01%55,407--Dec 31, 2023
VANGUARD HORIZON FUNDS0.01%146,428--Dec 31, 2023
VANGUARD INDEX FUNDS0.01%2,964,011651,18728.16%Dec 31, 2023
ALPS ETF Trust0.01%75,579--Feb 29, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,226--Dec 31, 2023
JNL VARIABLE FUND LLC0.01%28,975--Mar 31, 2020
TIAA-CREF LIFE FUNDS0.00%13,141--Dec 31, 2023
Fidelity Commonwealth Trust II0.00%20,861--Aug 31, 2023
Forethought Variable Insurance Trust0.00%11,196--Dec 29, 2023
FIDELITY CONCORD STREET TRUST0.00%448,40021,0944.94%Feb 29, 2024
Voya PARTNERS INC0.00%173,554--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%61,101--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%39,833--Dec 31, 2023
HARTFORD SERIES FUND INC0.00%56,862--Dec 31, 2023
MASSMUTUAL PREMIER FUNDS0.00%35,564--Dec 31, 2023
Calvert Variable Products, Inc.0.00%2,997--Dec 31, 2023
JOHN HANCOCK INVESTMENT TRUST0.00%78,363--Jan 31, 2024
SunAmerica Specialty Series0.00%306--Apr 30, 2021
Principal Exchange-Traded Funds0.00%6,305--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%33,227--Jan 31, 2024
HC CAPITAL TRUST0.00%11,674--Dec 31, 2023
COLLEGE RETIREMENT EQUITIES FUND0.00%376,069--Dec 31, 2023
RUSSELL INVESTMENT CO0.00%84,135--Jan 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%34,376--Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.00%2,100--Dec 31, 2023
ALLSPRING MASTER TRUST0.00%15,087--Feb 29, 2024
LoCorr Investment Trust0.00%5,507--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%19,40616,953691.11%Feb 29, 2024
Meeder Funds0.00%809--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%1,857--Dec 31, 2023
AIM VARIABLE INSURANCE FUNDS (INVESCO VARIABLE INSURANCE FUNDS)0.00%283,790--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%285,755--Feb 29, 2024
Legg Mason Global Asset Management Trust0.00%90,941--Jan 31, 2024
PGIM ETF TRUST0.00%6,400--Feb 29, 2024
ProFunds0.00%804--Jan 31, 2024
PACE SELECT ADVISORS TRUST0.00%26,108--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%6,791--Dec 31, 2023
MASTER INVESTMENT PORTFOLIO0.00%5,325--Dec 31, 2023
VALIC Co I0.00%17,588--Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%110,887--Feb 29, 2024
HARTFORD MUTUAL FUNDS INC/CT0.00%404,265--Jan 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%2,517--Dec 31, 2023
PENN SERIES FUNDS INC0.00%1,300--Dec 29, 2023
FINANCIAL INVESTORS TRUST0.00%2,843--Jan 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%4,290-1,078-20.08%Jan 31, 2024
Blackstone Alternative Investment Funds0.00%2,900-300-9.38%Dec 31, 2023
Dimensional ETF Trust0.00%8,890--Jan 31, 2024
T. Rowe Price Index Trust, Inc.0.00%331--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%1,545--Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%5,974--Feb 29, 2024
SUNAMERICA SERIES TRUST0.00%4,952--Jan 31, 2024
Brighthouse Funds Trust II0.00%28,848--Dec 31, 2023
DFA INVESTMENT DIMENSIONS GROUP INC0.00%12,930--Jan 31, 2024
NORTHERN FUNDS0.00%11,161--Dec 29, 2023
iShares U.S. ETF Trust0.00%1,013--Jan 31, 2024
Brighthouse Funds Trust I0.00%91,804--Dec 31, 2023
EQ ADVISORS TRUST0.00%8,767-1,298-12.90%Dec 31, 2023
iSHARES TRUST0.00%118,446--Feb 29, 2024
PACIFIC SELECT FUND0.00%22,684--Dec 31, 2023
MASSMUTUAL SELECT FUNDS0.00%4,792--Dec 31, 2023
Bridge Builder Trust0.00%13,520--Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%3,789--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%22--Jan 31, 2024
BlackRock Variable Series Funds, Inc.0.00%4,523--Dec 31, 2023
PRINCIPAL FUNDS, INC.0.00%4,317--Feb 29, 2024
BLACKROCK FUNDS0.00%3,909--Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%933--Dec 31, 2023
John Hancock Funds II0.00%6,083--Feb 29, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%6,500--Feb 29, 2024
VANGUARD WORLD FUND0.00%60--Feb 29, 2024

GlycoMimetics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 54.90K shares, compromising 0.11% of its total assets.

GlycoMimetics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 248139.66%
31 Dec, 235823.40%
30 Sep, 2347-11.32%
30 Jun, 2353-13.11%
31 Mar, 236127.08%
31 Dec, 224865.52%
30 Sep, 2229-3.33%
30 Jun, 2230-21.05%
31 Mar, 2238-17.39%
31 Dec, 2146-2.13%
30 Sep, 2147-18.97%
30 Jun, 2158-22.67%
31 Mar, 2175-16.67%
31 Dec, 209012.50%
30 Sep, 2080-4.76%
30 Jun, 208413.51%
31 Mar, 2074-7.50%
31 Dec, 19806.67%
30 Sep, 1975-3.85%
30 Jun, 1978-1.27%
31 Mar, 1979-2.47%
31 Dec, 1881-8.99%
30 Sep, 18891.14%
30 Jun, 1888-
31 Mar, 188811.39%
31 Dec, 177938.60%
30 Sep, 1757-17.39%
30 Jun, 176960.47%
31 Mar, 1743-14.00%
31 Dec, 16504.17%
30 Sep, 1648-5.88%
30 Jun, 165175.86%
31 Mar, 16293.57%
31 Dec, 1528-6.67%
30 Sep, 1530-3.23%
30 Jun, 153110.71%
31 Mar, 1528-
31 Dec, 14283.70%
30 Sep, 1427-12.90%
30 Jun, 1431-13.89%
31 Mar, 1436-

As of 31 Mar 24, 81 institutions are holding GlycoMimetics's shares, representing an increase of 39.66% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2436,848,9065.31%
31 Dec, 2334,990,1730.79%
30 Sep, 2334,716,628-2.32%
30 Jun, 2335,539,400-3.69%
31 Mar, 2336,902,18734.88%
31 Dec, 2227,358,8615.49%
30 Sep, 2225,934,578-1.88%
30 Jun, 2226,432,157-3.04%
31 Mar, 2227,260,030-7.03%
31 Dec, 2129,320,067-0.36%
30 Sep, 2129,426,427-5.21%
30 Jun, 2131,044,021-15.09%
31 Mar, 2136,560,722-5.25%
31 Dec, 2038,585,931-3.12%
30 Sep, 2039,827,729-1.26%
30 Jun, 2040,335,8861.76%
31 Mar, 2039,637,462-4.61%
31 Dec, 1941,553,079-0.13%
30 Sep, 1941,605,901-7.15%
30 Jun, 1944,808,447-1.41%
31 Mar, 1945,450,3040.54%
31 Dec, 1845,207,377-2.52%
30 Sep, 1846,377,1380.10%
30 Jun, 1846,332,3846.09%
31 Mar, 1843,672,24637.80%
31 Dec, 1731,692,3696.94%
30 Sep, 1729,634,328-1.92%
30 Jun, 1730,214,93157.97%
31 Mar, 1719,126,5501.02%
31 Dec, 1618,933,7592.87%
30 Sep, 1618,406,240-0.53%
30 Jun, 1618,503,81031.61%
31 Mar, 1614,059,0541.38%
31 Dec, 1513,867,664-23.31%
30 Sep, 1518,082,57031.35%
30 Jun, 1513,767,0090.16%
31 Mar, 1513,745,019-1.10%
31 Dec, 1413,897,5783.73%
30 Sep, 1413,398,153-0.88%
30 Jun, 1413,517,067-3.93%
31 Mar, 1414,070,230-

GlycoMimetics (GLYC) has 36.85M shares outstanding as of 31 Mar 24, up 5.31% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2457.22%1.94%
31 Dec, 2354.38%1.86%
30 Sep, 2354.01%1.56%
30 Jun, 2358.89%1.58%
31 Mar, 2361.15%2.29%
31 Dec, 2251.66%2.11%
30 Sep, 2249.47%1.94%
30 Jun, 2250.44%1.86%
31 Mar, 2252.09%1.60%
31 Dec, 2156.98%1.75%
30 Sep, 2157.07%1.57%
30 Jun, 2160.23%1.16%
31 Mar, 2172.12%1.01%
31 Dec, 2084.39%1.20%
30 Sep, 2083.83%0.99%
30 Jun, 2092.09%1.11%
31 Mar, 2090.96%0.99%
31 Dec, 1996.07%1.04%
30 Sep, 1996.10%0.89%
30 Jun, 19103.76%0.94%
31 Mar, 19105.29%0.96%
31 Dec, 18104.78%0.90%
30 Sep, 18107.68%0.92%
30 Jun, 18108.23%0.70%
31 Mar, 18124.22%1.53%
31 Dec, 1790.15%1.10%
30 Sep, 1790.56%0.74%
30 Jun, 17110.92%1.67%
31 Mar, 1781.46%1.21%
31 Dec, 1681.93%1.28%
30 Sep, 1679.86%0.91%
30 Jun, 1693.49%1.72%
31 Mar, 1673.72%1.39%
31 Dec, 1572.82%0.81%
30 Sep, 1595.04%1.81%
30 Jun, 1572.41%1.38%
31 Mar, 1572.49%1.34%
31 Dec, 1473.52%1.46%
30 Sep, 1470.91%1.37%
30 Jun, 1471.87%1.08%
31 Mar, 1481.65%-

As of 31 Mar 24, GlycoMimetics is held by 57.22% institutional shareholders, representing a 1.94% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 244981.48%
31 Dec, 2327125.00%
30 Sep, 2312-7.69%
30 Jun, 2313-62.86%
31 Mar, 233534.62%
31 Dec, 2226225.00%
30 Sep, 22814.29%
30 Jun, 227-36.36%
31 Mar, 2211-45.00%
31 Dec, 212042.86%
30 Sep, 2114-39.13%
30 Jun, 2123-28.13%
31 Mar, 2132-38.46%
31 Dec, 205285.71%
30 Sep, 2028-47.17%
30 Jun, 205339.47%
31 Mar, 2038-7.32%
31 Dec, 19412.50%
30 Sep, 194017.65%
30 Jun, 1934-17.07%
31 Mar, 194110.81%
31 Dec, 1837-13.95%
30 Sep, 1843-20.37%
30 Jun, 1854-10.00%
31 Mar, 186013.21%
31 Dec, 175370.97%
30 Sep, 1731-42.59%
30 Jun, 1754237.50%
31 Mar, 1716-40.74%
31 Dec, 162728.57%
30 Sep, 1621-46.15%
30 Jun, 1639254.55%
31 Mar, 1611-21.43%
31 Dec, 151416.67%
30 Sep, 1512-33.33%
30 Jun, 151812.50%
31 Mar, 151623.08%
31 Dec, 141330.00%
30 Sep, 1410-44.44%
30 Jun, 1418-50.00%
31 Mar, 1436-

49 institutional shareholders have increased their position in GLYC stock as of 31 Mar 24 compared to 27 in the previous quarter (a 81.48% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 249-30.77%
31 Dec, 2313-27.78%
30 Sep, 2318-5.26%
30 Jun, 231990.00%
31 Mar, 2310-23.08%
31 Dec, 2213116.67%
30 Sep, 226-50.00%
30 Jun, 2212-29.41%
31 Mar, 221730.77%
31 Dec, 2113-35.00%
30 Sep, 2120-9.09%
30 Jun, 2122-4.35%
31 Mar, 212321.05%
31 Dec, 2019-40.63%
30 Sep, 203245.45%
30 Jun, 2022-12.00%
31 Mar, 2025-3.85%
31 Dec, 192636.84%
30 Sep, 1919-38.71%
30 Jun, 193140.91%
31 Mar, 1922-15.38%
31 Dec, 18268.33%
30 Sep, 18249.09%
30 Jun, 182229.41%
31 Mar, 1817-15.00%
31 Dec, 172033.33%
30 Sep, 171536.36%
30 Jun, 1711-8.33%
31 Mar, 171250.00%
31 Dec, 168-46.67%
30 Sep, 1615200.00%
30 Jun, 165-37.50%
31 Mar, 16860.00%
31 Dec, 155-50.00%
30 Sep, 1510150.00%
30 Jun, 154-
31 Mar, 154-33.33%
31 Dec, 146-40.00%
30 Sep, 141011.11%
30 Jun, 149-
31 Mar, 14--

9 institutional shareholders have reduced their position in GLYC stock as of 31 Mar 24 compared to 13 in the previous quarter (a -30.77% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 248139.66%36,848,9065.31%57.22%1.94%4981.48%9-30.77%
31 Dec, 235823.40%34,990,1730.79%54.38%1.86%27125.00%13-27.78%
30 Sep, 2347-11.32%34,716,628-2.32%54.01%1.56%12-7.69%18-5.26%
30 Jun, 2353-13.11%35,539,400-3.69%58.89%1.58%13-62.86%1990.00%
31 Mar, 236127.08%36,902,18734.88%61.15%2.29%3534.62%10-23.08%
31 Dec, 224865.52%27,358,8615.49%51.66%2.11%26225.00%13116.67%
30 Sep, 2229-3.33%25,934,578-1.88%49.47%1.94%814.29%6-50.00%
30 Jun, 2230-21.05%26,432,157-3.04%50.44%1.86%7-36.36%12-29.41%
31 Mar, 2238-17.39%27,260,030-7.03%52.09%1.60%11-45.00%1730.77%
31 Dec, 2146-2.13%29,320,067-0.36%56.98%1.75%2042.86%13-35.00%
30 Sep, 2147-18.97%29,426,427-5.21%57.07%1.57%14-39.13%20-9.09%
30 Jun, 2158-22.67%31,044,021-15.09%60.23%1.16%23-28.13%22-4.35%
31 Mar, 2175-16.67%36,560,722-5.25%72.12%1.01%32-38.46%2321.05%
31 Dec, 209012.50%38,585,931-3.12%84.39%1.20%5285.71%19-40.63%
30 Sep, 2080-4.76%39,827,729-1.26%83.83%0.99%28-47.17%3245.45%
30 Jun, 208413.51%40,335,8861.76%92.09%1.11%5339.47%22-12.00%
31 Mar, 2074-7.50%39,637,462-4.61%90.96%0.99%38-7.32%25-3.85%
31 Dec, 19806.67%41,553,079-0.13%96.07%1.04%412.50%2636.84%
30 Sep, 1975-3.85%41,605,901-7.15%96.10%0.89%4017.65%19-38.71%
30 Jun, 1978-1.27%44,808,447-1.41%103.76%0.94%34-17.07%3140.91%
31 Mar, 1979-2.47%45,450,3040.54%105.29%0.96%4110.81%22-15.38%
31 Dec, 1881-8.99%45,207,377-2.52%104.78%0.90%37-13.95%268.33%
30 Sep, 18891.14%46,377,1380.10%107.68%0.92%43-20.37%249.09%
30 Jun, 1888-46,332,3846.09%108.23%0.70%54-10.00%2229.41%
31 Mar, 188811.39%43,672,24637.80%124.22%1.53%6013.21%17-15.00%
31 Dec, 177938.60%31,692,3696.94%90.15%1.10%5370.97%2033.33%
30 Sep, 1757-17.39%29,634,328-1.92%90.56%0.74%31-42.59%1536.36%
30 Jun, 176960.47%30,214,93157.97%110.92%1.67%54237.50%11-8.33%
31 Mar, 1743-14.00%19,126,5501.02%81.46%1.21%16-40.74%1250.00%
31 Dec, 16504.17%18,933,7592.87%81.93%1.28%2728.57%8-46.67%
30 Sep, 1648-5.88%18,406,240-0.53%79.86%0.91%21-46.15%15200.00%
30 Jun, 165175.86%18,503,81031.61%93.49%1.72%39254.55%5-37.50%
31 Mar, 16293.57%14,059,0541.38%73.72%1.39%11-21.43%860.00%
31 Dec, 1528-6.67%13,867,664-23.31%72.82%0.81%1416.67%5-50.00%
30 Sep, 1530-3.23%18,082,57031.35%95.04%1.81%12-33.33%10150.00%
30 Jun, 153110.71%13,767,0090.16%72.41%1.38%1812.50%4-
31 Mar, 1528-13,745,019-1.10%72.49%1.34%1623.08%4-33.33%
31 Dec, 14283.70%13,897,5783.73%73.52%1.46%1330.00%6-40.00%
30 Sep, 1427-12.90%13,398,153-0.88%70.91%1.37%10-44.44%1011.11%
30 Jun, 1431-13.89%13,517,067-3.93%71.87%1.08%18-50.00%9-
31 Mar, 1436-14,070,230-81.65%-36---

GlycoMimetics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 01, 2024Koenig Scottdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Goldberg Mark Alandirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024PEARSON TIMOTHY Rdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024King Rachel K.director-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Andrews Patricia Sdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024Jackson Scott Thomasdirector-A-AwardBuy40,000$1.62$64.80K40,000
May 01, 2024JUNIUS DANIEL Mdirector-A-AwardBuy40,000$1.62$64.80K40,000
Apr 02, 2024JUNIUS DANIEL Mdirector-A-AwardBuy5,209$3.00$15.63K98,459
Apr 02, 2024King Rachel K.director-A-AwardBuy3,334$3.00$10.00K515,194
Apr 02, 2024Goldberg Mark Alandirector-A-AwardBuy4,584$3.00$13.75K24,828
Jan 17, 2024Johnson Bruce Sofficer SVP & Chief Commercial OfficerA-AwardBuy250,000$3.11$777.50K250,000
Jan 17, 2024Semerjian Haroutdirector, officer Chief Executive OfficerA-AwardBuy695,000$3.11$2.16M695,000
Jan 17, 2024Rock Edwinofficer Chief Medical OfficerA-AwardBuy250,000$3.11$777.50K250,000
Jan 17, 2024Rath Chinmayaofficer SVP and Chief Business OfficerA-AwardBuy250,000$3.11$777.50K250,000
Jan 17, 2024Hahn Brian M.officer SVP Finance, CFOA-AwardBuy250,000$3.11$777.50K250,000
Jan 02, 2024Andrews Patricia Sdirector-A-AwardBuy5,191$2.36$12.25K58,608
Jan 02, 2024King Rachel K.director-A-AwardBuy4,238$2.36$10.00K511,860
Jan 02, 2024Goldberg Mark Alandirector-A-AwardBuy5,827$2.36$13.75K20,244
Oct 03, 2023Goldberg Mark Alandirector-A-AwardBuy9,167$1.50$13.75K14,417
Oct 03, 2023Andrews Patricia Sdirector-A-AwardBuy8,167$1.50$12.25K53,417

GlycoMimetics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20247--
Q1 20248--
Q4 20233--
Q3 20235--
Q2 2023102500.00%
Q1 2023121770.59%
Q4 202292450.00%
Q3 202211100.00%
Q2 202213--
Q1 202273233.33%
Q4 20211--
Q3 2021-2-
Q2 202112--
Q1 2021105200.00%
Q4 202083266.67%
Q2 20206--
Q1 202071700.00%
Q4 201911100.00%
Q3 201954125.00%
Q2 20196--

7 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by GlycoMimetics's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024---
Q4 2023---
Q3 20232--
Q2 202321200.00%
Q1 202381080.00%
Q4 202292450.00%
Q3 2022---
Q2 2022---
Q1 2022-3-
Q4 20211--
Q3 2021---
Q2 2021---
Q1 2021---
Q4 202061600.00%
Q2 2020---
Q1 20201--
Q4 2019---
Q3 20194--
Q2 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of GlycoMimetics's stocks.

GlycoMimetics Peer Ownership


TickerCompany
ANTXAN2 Therapeutics, Inc.
MLYSMineralys Therapeutics, Inc.
SPROSpero Therapeutics, Inc.
FHTXFoghorn Therapeutics Inc.
TILInstil Bio, Inc.
IVAInventiva S.A.
DYNDyne Therapeutics, Inc.
CUECue Biopharma, Inc.
BCABBioAtla, Inc.
ACHLAchilles Therapeutics plc
TRVITrevi Therapeutics, Inc.
NLTXNeurogene Inc.
ASMBAssembly Biosciences, Inc.
LIFEaTyr Pharma, Inc.

GLYC Ownership FAQ


GlycoMimetics is owned by institutional shareholders (57.22%), insiders (3.08%), and public (39.70%). The largest institutional shareholder of GlycoMimetics is BVF INC/IL (14.82% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.11% of total shares).

GlycoMimetics's major institutional shareholders are BVF INC/IL, ARTAL GROUP S.A., NEA MANAGEMENT COMPANY, LLC, OCTAGON CAPITAL ADVISORS LP, and VANGUARD GROUP INC. The top five shareholders own together 43.06% of the company's share outstanding.

As of Mar 2024, there are 81 institutional shareholders of GlycoMimetics.

BVF INC/IL owns 9.54M shares of GlycoMimetics, representing 14.82% of the company's total shares outstanding, valued at $28.63M (as of Mar 2024).

As of Mar 2024, ARTAL GROUP S.A holds 8.59M shares of GlycoMimetics (GLYC), compromising 13.34% of the company, valued at $25.77M.

NEA MANAGEMENT COMPANY, LLC is the third largest holder of GlycoMimetics. The company owns 3.84M of the company's shares outstanding (worth $11.51M).